Literature DB >> 15185789

Phacoemulsification cataract extraction and intraocular lens implantation in patients with Behçet's disease.

Nilufer Berker1, Emel Soykan, Ufuk Elgin, Seyhan Sonar Ozkan.   

Abstract

BACKGROUND AND
OBJECTIVE: To evaluate the outcomes of phacoemulsification cataract extraction and intraocular lens implantation in patients with Behçet's disease. PATIENTS AND METHODS: This prospective study was based on 40 eyes of 34 patients with Behçet's disease who underwent phacoemulsification cataract extraction and intraocular lens implantation between May 2000 and February 2003. Their postoperative ocular complications and visual outcomes were observed during a mean follow-up period of 18.35 +/- 6.17 months (range, 6 to 32 months).
RESULTS: Postoperative visual acuity increased in 29 eyes (72.5%) and was 20/40 or better in 18 eyes (45%). It decreased in 7 eyes (17.5%), resulting in a visual acuity of 20/400 or worse. The most frequent postoperative complication was posterior capsular opacification, which developed in 15 eyes (37.5%). Other complications were posterior synechiae formation in 7 eyes (17.5%), severe inflammation in 5 eyes (12.5%), cystoid macular edema in 5 eyes (12.5%), epiretinal membrane in 3 eyes (7.5%), and optic atrophy in 2 eyes (5%).
CONCLUSION: With appropriate preoperative and postoperative suppression of inflammation, phacoemulsification and intraocular lens implantation are safe procedures leading to visual improvement in patients with Behçet's disease without preexisting fundus lesions.

Entities:  

Mesh:

Year:  2004        PMID: 15185789

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  11 in total

1.  Visual aspects of Behçet's disease.

Authors:  Tulay Kansu; Sibel Kadayifcilar
Journal:  Curr Treat Options Neurol       Date:  2006-01       Impact factor: 3.598

Review 2.  Visual aspects of Behçet's disease.

Authors:  Tulay Kansu; Sibel Kadayifcilar
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

3.  Intraocular surgery under systemic interferon-alpha therapy in ocular Adamantiades-Behçet's disease.

Authors:  Lothar Krause; Andreas Altenburg; Nikolaos E Bechrakis; Gregor Willerding; Christos C Zouboulis; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-13       Impact factor: 3.117

4.  Analysis of clinical features and visual outcomes of pars planitis.

Authors:  Nilufer Berker; Emine Sen; Ufuk Elgin; Cemile Ucgul Atilgan; Erdem Dursun; Pelin Yilmazbas
Journal:  Int Ophthalmol       Date:  2017-04-07       Impact factor: 2.031

5.  Cataract surgery in patients with history of uveitis.

Authors:  Ujwala Baheti; Sana S Siddique; C Stephen Foster
Journal:  Saudi J Ophthalmol       Date:  2012-01

6.  Serum levels of Th17-related cytokines in Behcet disease patients after cataract surgery.

Authors:  Shuhong Jiang; Xialin Liu; Lixia Luo; Bo Qu; Xiangkun Huang; Ying Lin; Shaobi Ye; Yizhi Liu
Journal:  Mol Vis       Date:  2011-05-31       Impact factor: 2.367

7.  Cataract surgery in uveitis.

Authors:  Rupesh Agrawal; Somashiela Murthy; Sudha K Ganesh; Chee Soon Phaik; Virender Sangwan; Jyotimai Biswas
Journal:  Int J Inflam       Date:  2012-02-08

Review 8.  Decision-making and management of uveitic cataract.

Authors:  Nicole Shu-Wen Chan; Seng-Ei Ti; Soon-Phaik Chee
Journal:  Indian J Ophthalmol       Date:  2017-12       Impact factor: 1.848

9.  Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease.

Authors:  Abdullah Alfawaz; Sultan Alrashidi; Hatem Kalantan; Hani Al-Mezaine; Ahmed M Abu
Journal:  Ann Saudi Med       Date:  2014 Jul-Aug       Impact factor: 1.526

10.  Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease.

Authors:  Fouad R Zakka; Peter Y Chang; Gian P Giuliari; C Stephen Foster
Journal:  Clin Ophthalmol       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.